Jeff Jaeckel

Co-chair Global Antitrust Law Practice Group | Washington, D.C.
|
(202) 778-1440

Events

Experience

Represented SoftBank in its $21.6 billion acquisition of a 78% interest in U.S. wireless operator Sprint Nextel. The transaction was the largest announced U.S. M&A transaction of 2012, the largest outbound investment ever from Asia, and the largest U.S. M&A transaction in Japan’s history.

Represented Elpida Memory, a Tokyo-based DRAM manufacturer, in its $2.5 billion sale to Micron Technologies, making Micron the world’s second-largest DRAM manufacturer.

Represented SoftBank in connection with the acquisition by Sprint Nextel of the approximately 50% of the equity of Clearwire Corporation that Sprint does not already own for a purchase price of approximately $4 billion, resulting in a total Clearwire enterprise value of approximately $14 billion.

Represented major international transportation company in connection with an investigation in the U.S., Japan, and South Korea related to alleged price-fixing in the air cargo industry.

Represents major international transportation company in the U.S., EU, Brazil, and Asia in connection with an investigation of alleged price-fixing in the freight forwarding industry and related class action civil litigation.

Represents AirTran Airways in a Department of Justice investigation into allegations that our client conspired with Delta Air Lines to set airline baggage fees, and in parallel class action civil litigation.

Secured summary judgment on behalf of international transportation company in antitrust litigation alleging that our client conspired with FedEx to boycott certain consultants in the shipping industry .

Represents Asian semiconductor manufacturer in connection with an investigation in the U.S., EU, and Canada related to allegations of price-fixing.

Represented Astellas Pharma Inc. before the Federal Trade Commission in its $4 billion tender offer for OSI Pharmaceuticals Inc., the second largest U.S. acquisition by a Japanese pharmaceutical firm.

Represented Tanox Inc. before the Federal Trade Commission in its $919 million acquisition by Genentech.

Represented AirTran Holdings, Inc. before the U.S. Department of Justice in connection with Southwest Airlines Co.’s $1.4 billion acquisition of AirTran.

Represented ON Semiconductor Corp. in connection with its $600 million acquisition of Sanyo Semiconductor Co. Ltd.

Represented Clearwire Corporation, an innovative wireless communications company developing next-generation wireless broadband technology called WiMAX, before the U.S. Department of Justice in a deal with Sprint Nextel Corporation, Intel Corporation, Google, Inc., Comcast Corporation, Time Warner Cable Inc., and Bright House Networks to create a national WiMAX joint venture valued at approximately $14.5 billion.

Represented Astellas Pharma Inc., Japan’s second-largest drug maker, in its acquisition of Agensys Inc., a leading U.S.-based biotechnology unit developing several novel cancer treatments.

Represented Fujisawa Pharmaceutical Co. and Yamanouchi Pharmaceutical Co. before the Federal Trade Commission in connection with its $7 billion merger to form Astellas Pharma Inc., Japan’s second-largest pharmaceutical company.

Represented Celltech Ltd. in intellectual property and antitrust litigation against MedImmune Inc.

Represented Sankyo Co. and Daiichi Pharmaceutical Co. before the Federal Trade Commission in relation to its multibillion-dollar merger to form Daiichi Sankyo.

Represented Alltel Corporation before the Department of Justice in its $28 billion acquisition by Texas Pacific Group and Goldman Sachs, and in its $28.5 billion acquisition by Verizon Wireless to create the largest wireless operator in the U.S.


Chambers USA 2021

Ranked for Antitrust, District of Columbia

Chambers USA 2020

Recognized Practitioner – DC Antitrust